JNJ - Johnson & Johnson Ordered To Pay $260M In Latest Talc Trial | Benzinga
A jury has ruled that Johnson & Johnson (NYSE:JNJ) must pay $260 million to an Oregon woman who claims to have developed mesothelioma from using the company’s talc powder.
What Happened: The jury’s decision, announced on Monday, includes $60 million in compensatory damages and $200 million in punitive damages, Reuters reported on Tuesday. The plaintiff, Kyung Lee, was diagnosed with mesothelioma at the age of 48, allegedly due to inhaling asbestos-tainted talc over a period of 30 years.
Despite the verdict, J&J plans to appeal, with Erik Haas, the company’s worldwide vice president of litigation, stating that the decision ...